.png)
By Michael Schindler, CEO of MedITEX
Building on our current portfolio, our strategic direction is to evolve from “the number one fertility EMR” into a fully integrated, intelligent IVF ecosystem that supports every stakeholder in reproductive medicine. At the core remains MedITEX IVF: an all‑in‑one solution that digitizes the entire clinical workflow, with comprehensive cycle documentation, quality assurance, statistical analysis and seamless submission to national registries. Around this core, we are expanding MedITEX Cloud into a set of tightly connected, cloud‑based services.
Patient‑centric tools such as MedITEX Connect (patient portal), the Hope App (digital patient support) and MedITEX Survey (digital medical history) already extend the IVF journey beyond the clinic walls, enabling secure communication, remote preparation and better‑informed patients. On the data side, MedITEX IVF Registry and related solutions provide tailor‑made infrastructure for national competent authorities and scientific groups to collect, standardize and analyze IVF data at scale. Together, these components form a uniquely powerful platform for both day‑to‑day care and long‑term research and quality improvement.
Looking ahead, our ambition is to make this ecosystem the reference infrastructure for data‑ and AI‑driven reproductive medicine. This means deepening interoperability with lab devices, hospital information systems and genetic laboratories; enriching our data models to capture embryo‑level, protocol‑level and long‑term outcome data; and providing advanced analytics and decision‑support capabilities on top of this foundation.
As clinics adopt time‑lapse imaging, AI‑based embryo scoring, personalized stimulation protocols and complex genetic testing, MedITEX should be the place where all these data streams converge in a structured, auditable and clinically meaningful way. In parallel, we will further strengthen patient‑facing components to support telemedicine, cross‑border care and long‑term follow‑up, ensuring that patients experience a consistent digital journey from initial consultation to pregnancy and beyond.
Finally, through MedITEX Cloud cooperations, we will open our platform to research groups and industry partners, providing controlled access to de‑identified data and to a global network of clinics. In doing so, we aim to be not just a software vendor, but a strategic partner in shaping the future of reproductive medicine – enabling safer, more effective and more human‑centered fertility care worldwide.
